Search results
New Outlook On Biogen Inc – Stocks Register
Stocks Register· 1 day agoBiogen Inc (NASDAQ:BIIB) price on Friday, May 10, fall -0.56% below its previous day’s close as a downside momentum from buyers pushed the stock ...
Biogen (NASDAQ:BIIB) Given New $342.00 Price Target at HSBC
ETF DAILY NEWS· 5 days agoBTIG Research restated a neutral rating on shares of Biogen in a report on Sunday, January 7th. UBS Group dropped their price objective on Biogen ...
Undervalued by 28%, This Stock Is a Buy for Patient Investors
Morningstar· 4 days agoBiogen BIIB is having a tough year: Its shares are down 15% through early May. The wide-moat...
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks via Yahoo Finance· 4 days agoScore takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the...
Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen
GuruFocus.com via Yahoo Finance· 4 days agoKey Position Reductions Significant reductions were made in 106 stocks, including: Biogen Inc...
3 S&P 500 Stocks to Rival Nvidia's 2023 Performance in the Second Half of 2024
InvestorPlace· 1 day agoThe extraordinary performance of Nvidia (NASDAQ:NVDA) in 2023 coincided with a seismic generative-AI...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 3 days agoThe decision effectively pushes back the approval decision, which was expected in the first quarter....
AbCellera Biologics Q1 2024 Earnings Preview
Seeking Alpha· 6 days agoAbCellera Biologics is set to announce its Q1 earnings results, with a consensus EPS estimate of -$0.16 and a revenue estimate of $10.85M.
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
InvestorPlace· 3 days agoTo investors, the value of a drug is based on how much it increases a pharmaceutical company’s...
Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
Zacks· 4 days agoDenali (DNLI) Q1 loss narrows year over year due to lower expenses despite nil revenues.